Skip to main content

Table 1 Antibodies, company, clone, pre-treatment and dilution of used antibodies.

From: Cytokeratin 8/18 expression indicates a poor prognosis in squamous cell carcinomas of the oral cavity

Antibody

Company

Clone

Pre-treatment

Dilution

Ck 5/6

DAKO, Glostrup, Denmark

D5/16B4

Autoclave 10 min

1 : 80

Ck 8/18

Dianova, Hamburg, Germany

K8.8/DC10

Autoclave 10 min, citrate buffer

1 : 40

Ck 1

Novocastra, Newcastle, UK

34βB4

Steamer 30 min, citrate buffer

1 : 150

Ck 10

DAKO, Glostrup, Denmark

DE-K10

Steamer 30 min, citrate buffer

1 : 400

Ck 14

Dianova Hamburg, Germany

LL002

Steamer 30 min, citrate buffer

1 : 50

Ck 19

Quartett GmbH, Berlin, Germany

KS19.1

Steamer 30 min, citrate buffer

1 : 80

Vimentin

Ventana Inc., Tucson, USA

V9

Steamer 30 min, citrate buffer

1 : 1000